Predoctoral Fellowship in Health Outcomes
Pharmacoeconomics, Health Care Economic Information, Real World Data and Health Outcomes Program (Health Outcomes Research) spans a broad spectrum of issues related to health care delivery, from studies evaluating effectiveness of a pharmaceutical intervention, to the impact of reimbursement policies on outcomes of care. It also ranges from the development and use of patient-level real-world data and tools to perform patient-based assessments and evaluate patient-centered outcomes to analyses of ways in which results of Health Outcomes Research are disseminated to providers or consumers to encourage behavior change.
Health Outcomes Research incorporates a variety of methods, data, and tools from different disciplines including machine learning, simulations and other analytical tools. The application of Health Outcomes Research principles in evaluating the design, delivery, safe use and effectiveness of pharmaceuticals includes but is not limited to the following general areas:
- Pharmacoeconomics evaluates behavior of individuals, organizations, and markets concerning use of pharmaceutical products, services, and programs. The discipline frequently focuses on costs (inputs) and consequences (outcomes) of pharmaceutical use. Evaluations of novel therapies, such as cell and gene therapy, are strongly encouraged.
- Health Care Economic Information is an analysis that identifies, measures, or describes the economic consequences, which may be based on the separate or aggregated clinical consequences of the represented health outcomes, of the use of a drug.
- Clinical Outcomes Assessment (COA) includes Patient Reported Outcomes, Clinician-Reported Outcomes, Performance Outcomes, Patient-Centered Outcomes and Observer-Reported Outcomes. COA focuses on the value assigned to duration of life as modified by the impairment of physical, social, and psychological functional states, symptoms, satisfaction, perceptions, and opportunities influenced by disease, injury, treatment, or policy. Comparative effectiveness proposals of therapeutics and non-therapeutic treatments are welcome.
- Patient-level Real-World Data and Analytic Tools: Health Outcomes Research depends on the evolving and increasing use, and evaluation of technologies, analyses and patient-level databases (e.g. electronic medical records, health insurance claims data, registries, patient health-networks, patient health status monitoring) to assist in better understanding diseases and interventions.
Up to two years
$25,000 per year
- Students just beginning graduate school should not apply.
- Applicants (U.S. and non-U.S. citizens) attending U.S. schools of medicine, pharmacy, public health, nursing, and dentistry are eligible for this award.
- A candidate enrolled in an MD/PhD program should not be taking required clinical coursework or clerkships while the fellowship is active.
- The department chair or graduate officer is expected to verify the student’s doctoral candidacy.
- Eligible candidates will have completed most of their pre-thesis requirements (at least two years of coursework) and be engaged in thesis research as PhD candidates by the time the award is activated.
- Predoctoral Fellowships are designed for students who expect to complete their PhD requirements in two years or less from the time the fellowship begins.
- Award activation may be as early as July 1, 2022 or on the first day of any month thereafter, up to and including December 1, 2022.
- Fellows are expected to devote full time (including summers) to their research.
- Predoctoral Fellowships should not be seen as a way to fund the principal investigator’s currently funded research project.
- If multiple applicants from the same lab are submitting proposed efforts on the same project, the efforts must be separate activities. They may not be duplicative. We will not consider multiple applications for the same or similar efforts on the same project. This pertains to submissions from all three categories of our programs within Health Outcomes Research. The applications will be disqualified.